Lab software firm Scitara raised $15 million in a recent funding round, Bio-IT World reported Feb. 8.
The series B funding round investment was led by Northpond Ventures, which has already invested in the company, the report said. Flybridge Capital also participated in the funding round.
The company said the investment will help fuel its growth plans for 2022, with an aim at solving lab data integration problems.